mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.07 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.08 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.08 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |